Compounds > 3-hydroxybenzylhydrazine
Page last updated: 2024-10-21

3-hydroxybenzylhydrazine and Anterior Circulation Transient Ischemic Attack

3-hydroxybenzylhydrazine has been researched along with Anterior Circulation Transient Ischemic Attack in 2 studies

3-hydroxybenzylhydrazine: decarboxylase inhibitor; RN given refers to parent cpd; structure

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Misu, Y2
Furukawa, N2
Arai, N2
Miyamae, T2
Goshima, Y2
Ohshima, E1
Suzuki, F1
Fujita, K1

Other Studies

2 other studies available for 3-hydroxybenzylhydrazine and Anterior Circulation Transient Ischemic Attack

ArticleYear
[Is endogenously released DOPA itself an upstream factor for increase in glutamate release and delayed neuronal cell death induced by transient ischemia in rats?].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1998, Volume: 112 Suppl 1

    Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Cell Death; Corpus Striatum; Dihydroxyphenyla

1998
Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata.
    Journal of neurochemistry, 2001, Volume: 76, Issue:3

    Topics: Animals; Cell Death; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enzyme Inhibitors; Glutamic

2001